BRIEF published on 10/05/2026 at 19:22, 1 day 7 hours ago IntegraGen: Decision expected on the divestment plan Judicial Reorganization IntegraGen Commercial Court Takeover Bids Decision Expected
BRIEF published on 09/11/2026 at 20:45, 25 days 5 hours ago IntegraGen: two takeover bids filed in receivership Judicial Reorganization Genomics IntegraGen Resumption Commercial Court Of Évry
BRIEF published on 06/15/2026 at 20:31, 3 months 21 days ago IntegraGen is heading towards receivership to ensure its survival. Sustainability Judicial Reorganization Genomics Industrial Partnerships Strategic Activities
BRIEF published on 02/20/2026 at 20:20, 7 months 14 days ago IntegraGen: Annual Review and Continued Strategic Refocusing Revenue Treasury Certifications Profitability Biopharma
BRIEF published on 10/29/2025 at 17:50, 11 months 8 days ago IntegraGen: Lower Results, Reduced Expenses in the First Half of 2025 Financial Results Treasury Cost Reduction Genomics CLIA/CAP Certification
BRIEF published on 07/02/2025 at 07:35, 1 year 3 months ago IntegraGen Reports Decline in Sales and Cash Reserves Sales Decline Operational Costs IntegraGen Financing Needs Genomic Analyses
PRESS RELEASE published on 07/02/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases IntegraGen reports sales of €2.5 million in the first half of 2025, a 31% decrease in sequencing activities at Évry and challenges with cash position leading to exploration of strategic options Sales Cash Position Strategic Options IntegraGen Decrease
BRIEF published on 01/15/2025 at 18:49, 1 year 8 months ago IntegraGen revenue down for 2024 Treasury Growth Turnover Genomics SeqOIA
PRESS RELEASE published on 01/15/2025 at 18:44, 1 year 8 months ago Inside Information / Information on annual revenues IntegraGen, an OncoDNA Group company, reports 27% revenue drop in 2024 due to SeqOIA services cessation. Cash position at €1.9m. Growth seen outside SeqOIA Cash Position Growth Prospects Revenue Drop SeqOIA IntegraGen
BRIEF published on 07/18/2024 at 18:49, 2 years 2 months ago IntegraGen: Revenue up despite loss of SeqOIA Growth Turnover CLIA Certification SeqOIA Genomic
Published on 10/07/2026 at 01:45, 45 minutes ago Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:05, 1 hour 25 minutes ago Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/06/2026 at 23:45, 2 hours 45 minutes ago Gamma Resources Closes $1,750,000 Private Placement
Published on 10/06/2026 at 23:32, 2 hours 58 minutes ago Battery X Metals Announces Closing of First Tranche of Private Placement Financing
Published on 10/06/2026 at 19:05, 7 hours 25 minutes ago Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Published on 10/06/2026 at 18:30, 8 hours ago Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International
Published on 10/06/2026 at 18:00, 8 hours 30 minutes ago ARVERNE GROUP: Total number of shares and voting rights in the share capital as of September 30, 2026
Published on 10/06/2026 at 17:45, 8 hours 45 minutes ago EQS-Adhoc: Airbus SE: Airbus reports share buyback transactions 28 Sept. to 02 Oct. 2026
Published on 10/06/2026 at 19:15, 7 hours 15 minutes ago Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 18:39, 7 hours 50 minutes ago Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 8 hours 15 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026
Published on 10/06/2026 at 18:00, 8 hours 30 minutes ago Information concerning the total number of voting rights and shares in the share capital as of October 2, 2026
Published on 10/06/2026 at 17:45, 8 hours 45 minutes ago Aéroports de Paris SA - Shares and voting rights as of 30 Septembre 2026
